Holen Sie sich die Stockscreener-App
8.11
4.14%
-0.35
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC) - The Globe and Mail
Form 8K Benitec Biopharma Ltd ADR For: 24 September By Investing.com - Investing.com India
An auditor in place since 2020 is out at Benitec Biopharma (BNTC). Ernst & Young is named, pending acceptance. - Stock Titan
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
Benitec Biopharma FY 2026 Earnings: Revenue Flat at $0, Net Loss Widens to $45.5 Million - Sci-Tech Today
Benitec Biopharma (NASDAQ: BNTC) Reports $180M Cash Reserves as BB-301 Trial Progresses Toward 2027 Milestone - Kalkine Media
Benitec (NASDAQ: BNTC) prepares $200M shelf that may back its lead gene therapy - Stock Titan
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update - GlobeNewswire
Benitec Biopharma Files $200 Million Shelf Registration - Yahoo Finance
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Enterprise value to revenue forward of Benitec Biopharma Inc. – NASDAQ:BNTC - TradingView
Benitec Biopharma Inc.ADR Peer Comparison – Compare with Others - Value Research
Benitec Biopharma Inc.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Benitec (BNTC) Trading: Moves 5.71% Lower to $12.71 for the Current Session; Next Session: the $12.07 to $13.35 Range Remains in Focus in the Latest ReadingBuffered ETF - vinanet.vn
Benitec (BNTC) Levels: Posts a 4.33% Loss to $12.80 in the Latest Session; Current Setup: Price Remains Between $12.16 Support and $13.44 Resistance at the CloseVolume Spike Alerts - vinanet.vn
Benitec (BNTC) Earnings Update: The EPS Result Is Above Expectation for the Current Session; Price Reaction: The Market Price Advances 3.88% in the Latest ReadingLow Growth Earnings - vinanet.vn
Benitec (BNTC) EPS and Revenue: EPS Beats Its Estimate in Latest Trading; Latest Reaction: Shares Close 1.45% Lower on the DayPeak Earnings Alert - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Trading Systems Reacting to (BNTC) Volatility - Stock Traders Daily
BNTC Q2 2026 Earnings: Loss Narrows More Than Expected as EPS Beats Estimates by 14%Profit Guidance Range - vinanet.vn
Benitec Biopharma (BNTC) Advances 3% as Shares Test Key Resistance LevelUnusual Call Volume - Vinanet
Benitec Biopharma (BNTC) Advances 3% as Shares Test Key Resistance LevelTechnical Analysis - siam.in
BNTC Q2 2026 Earnings: EPS Beats Estimates Despite Revenue Absence and Share DeclineEarnings Growth Analysis - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50 Day Moving AverageTime to Sell? - marketbeat.com
Companies Like Benitec Biopharma (NASDAQ:BNTC) Can Afford To Invest In Growth - moomoo.com
Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Sahm
Benitec Biopharma Inc (BNTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
How Benitec Biopharma Inc. (BNTC) Affects Rotational Strategy Timing - Stock Traders Daily
Benitec Biopharma (BNTC) Slips 1.26% as Shares Test Key Support at $11.12Factor Crowding - dars.gov.et
Benitec Biopharma (BNTC) Slips 1.26% as Shares Test Key Support at $11.12Ichimoku Kumo Break - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
BNTC Initiated by Wedbush -- Rating Set to Outperform with PT at $16.00 - GuruFocus
BNTC Initiated by Wedbush -- Rating Set to Outperform with PT at $16.00 - GuruFocus
Wedbush Initiates Coverage on Benitec Biopharma (BNTC) with Outp - GuruFocus
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Benitec Biopharma Inc (BNTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Benitec Biopharma Inc (BNTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.710|Chg%:+0.240 - TradingKey
Benitec Biopharma Inc (BNTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.540|Chg%:+0.070 - TradingKey
TradingKey - TradingKey
Benitec Biopharma Inc (BNTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BNTC Q2 2026 Earnings: EPS Beats Estimates Despite No Revenue, Shares Edge HigherProfit Margin Analysis - Vinanet
BNTC|Benitec Biopharma Inc|Price:11.470|Chg%:+0.030 - TradingKey
Benitec Biopharma Inc (BNTC) Institutional Confidence - TradingKey
Benitec Biopharma Inc (BNTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
(BNTC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
(BNTC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Benitec Biopharma (BNTC) Retraces 1.72% – Navigating Key Support and Resistance LevelsIV Crush Alert - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):